Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm
Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the ...
pharmaphorum28d
Jimenez to step down as Novartis chief, Narasimhan takes over
but decided that Vasant Narasimhan, known as Vas, was the best candidate to take the company forward. Jimenez joined Novartis from a commercial role at Heinz with no experience in the pharma ...
Hosted on MSN7mon
Novartis CEO Narasimhan’s Pay Almost Doubles to $18.8 Million
(Bloomberg) -- Novartis AG Chief Executive Officer Vas Narasimhan’s compensation almost doubled to 16.25 million Swiss francs ($18.8 million) last year, even as the Swiss drugmaker tries to ...
Fortune11mon
Vas Narasimhan
Dr. Vas Narasimhan is CEO of Novartis, one of the world’s most innovative medicines companies, since 2018. During his career at Novartis, he has overseen the licensure of more than 30 novel ...
pharmaphorum7y
Interview: Vas Narasimhan on Novartis' goal to lead in CAR-T therapies
Novartis’ head of drug development Vas Narasimhan talks about the company’s stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions ...
Business Insider India5y
Pharma giant Novartis has been on a tear. CEO Vas Narasimhan told us how wearing jeans to work is helping transform the Swiss company.
Ever since Vas Narasimhan first stepped into the CEO role at the Swiss drug giant Novartis last year, he's been working to set the company on a new path. The goal was to reshape the Swiss pharma ...